Thomas Kent

Insider profile

Currently holds a position at Tekla Life Sciences Investors

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Trustee Tekla Life Sciences Investors Jan. 1, 2017 -
Thomas Kent's trades of abrdn World Healthcare Fund's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
135.39
Quantity 5,491 +28.8%
Value US$801,254
Transaction date
Purchase
Price
15.55
Quantity 76,771 +44.2%
Value US$1,011,284
Transaction date
Purchase
Price
14.52
Quantity 1,800 New position
Value US$26,128
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-01-29 2018-01-25
B Purchase
5,491 +28.8%
135.39
US$801,254 		5,491 +28.8% 135.39 US$801,254
2018-01-29 2018-01-25
B Purchase
77,874 -11.3%
127.03
US$3,612,743 		77,874 -11.3% 127.03 US$3,612,743
2018-01-29 2018-01-25
B Purchase
76,771 +44.2%
15.55
US$1,011,284 		76,771 +44.2% 15.55 US$1,011,284
2018-01-29 2018-01-25
B Purchase
1,800 New position
14.52
US$26,128 		1,800 New position 14.52 US$26,128